Trilavir Mini Tablet contains the active substances Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate. Trilavir Mini composition includes Efavirenz, an antiretroviral from the nonnucleoside reverse transcriptase inhibitors (NNRTIs) class, while Lamivudine and Tenofovir Disoproxil Fumarate are antiretroviral medicines belonging to nucleotide reverse transcriptase inhibitors (NRTI) class. Trilavir Mini tablet manufacturer produces this combination medication for HIV treatment. Trilavir Mini Tablet dosage should be determined by your healthcare provider based on your individual condition. Do not take this medication if you are allergic to Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate, or its other medical ingredients. Patients diagnosed with pancreatitis or at risk of pancreatitis should take this combination medicine cautiously. During treatment, your doctor may periodically monitor your blood counts, bone mineral density, and liver and kidney parameters to prevent serious complications. Report to your doctor if you have or had a history of heart failure (QT prolongation), seizures, mental health issues, pancreatitis (inflammation in the pancreas), bone disease (osteonecrosis - death of bone tissue), fractures, liver (chronic hepatitis B or C), or kidney problems. Inform your doctor if you are planning to get pregnant or think you may be pregnant. Breastfeeding is not recommended while taking this medication due to potential HIV transmission from mother to baby. Trilavir Mini Tablet price varies by location and pharmacy. Buy Trilavir Mini Tablet online from authorized healthcare providers. Trilavir Mini Tablet substitute options are available; consult your doctor before switching. Trilavir Mini Tablet review from patients highlights its effectiveness in HIV management. When comparing Trilavir Mini vs Viraday, discuss with your healthcare provider to determine the most suitable option for your treatment needs.